Skip to main content
. 2026 Feb 19;26:638. doi: 10.1186/s12879-026-12930-6

Table 3.

Antimicrobial consumption from 2019 to 2025 Q1-Q2

Year/Period Total patient-days DDD of Vancomycin Vancomycin DDD per 1,000 Patient-Days DDD of Linezolid Linezolid DDD per 1,000 Patient-Days
2019 559,794 4000.75 7.15 2593.00 4.63
2020 432,063 2248.83 5.20 1911.30 4.42
2021 479,973 2264.55 4.72 2462.04 5.13
2022 431,681 4361.41 10.10 3554.30 8.23
2023 551,141 2926.31 5.31 3370.27 6.12
2024 592,464 3838.93 6.48 4432.27 7.48
2025 Q1-Q2 231,946 1545.59 6.66 2183.64 9.41

DDD: defined daily dose. Q: quarter